1LLY:BIT
Eli Lilly And Co
1 017,40 €
arrow_downward
-0,57%(-5,80) 1K
2-okt, 17:29:23 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1LLY tikeri uchun statistika yaratilmoqda...
Ochish
1 023,60 €
Yuqori
1 031,00 €
Past
1 016,00 €
Bozor kapitali
1,11 trln
Oʻrtacha hajm
382,00
Hajmi
492,00
52 haftalik eng yuqori
1 106,80 €
52 haftalik eng past
640,70 €
Xodimlar soni
50 ming
Ochish
1 023,60 €
Yuqori
1 031,00 €
Past
1 016,00 €
Bozor kapitali
1,11 trln
Oʻrtacha hajm
382,00
Hajmi
492,00
52 haftalik eng yuqori
1 106,80 €
52 haftalik eng past
640,70 €
Xodimlar soni
50 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
7 soat oldin
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Investing.com
·
10 soat oldin
Lilly presents exploratory biomarker data from psoriasis study
Seeking Alpha
·
12 soat oldin
Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share (LLY:NYSE)
Stock Traders Daily
·
12 soat oldin
Discipline and Rules-Based Execution in LLY Response
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Eli Lilly And Co haqida
CEODavid A. Ricks
Xodimlar soni50 ming
Asos solingan1876
Bosh ofislarIndianapolis, Indiana, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytlilly.com